Wednesday, June 10, 2026

pharma Β· Pyruvate Kinase Deficiency Β· Sickle Cell Disease Β· AGIO

Agios Netherlands

Agios Netherlands trial registry β€” 51 ClinicalTrials.gov studies with program phase, status, and indication context.

CAMBRIDGE, MA, NL HQ
1978 Founded
20 Employees
Public company Type
AGIO Β· NYSE Ticker
Company details
Status
Public
HQ
CAMBRIDGE, MA, NL
Founded
1978
Employees
20
Programs
45
Drugs
15
Patents
93
Intelligence Β· Clinical Trials

Agios Netherlands clinical trials

Registry index of 51 ClinicalTrials.gov studies linked to Agios Netherlands programs β€” each row shows trial ID, program name, phase, status, and indication.

Agios Netherlands trial registry β€” 51 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Agios Netherlands.

  1. Placebo Matching Mitapivat β€” Phase 3

    Clinical update
  2. Mitapivat β€” Phase 3

    Clinical update
  3. Mitapivat β€” Approved

    Clinical update
  4. Mitapivat β€” Phase 3

    Clinical update
  5. Mitapivat β€” Phase 3

    Clinical update
  6. Mitapivat β€” Phase 1

    Clinical update
  7. Mitapivat β€” Phase 1

    Clinical update
  8. Mitapivat β€” Phase 2

    Clinical update

Trial registry

51 studies